182 related articles for article (PubMed ID: 109501)
1. Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.
Jones RJ
J Hyg (Lond); 1979 Jun; 82(3):453-62. PubMed ID: 109501
[TBL] [Abstract][Full Text] [Related]
2. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
3. Controlled trials of a polyvalent pseudomonas vaccine in burns.
Jones RJ; Roe EA; Gupta JL
Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
[TBL] [Abstract][Full Text] [Related]
4. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
Jones RJ; Roe EA
Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
[TBL] [Abstract][Full Text] [Related]
5. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
[No Abstract] [Full Text] [Related]
6. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
[No Abstract] [Full Text] [Related]
7. Low mortality in burned patients in a Pseudomonas vaccine trial.
Jones RJ; Roe EA; Gupta JL
Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
[TBL] [Abstract][Full Text] [Related]
8. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay (ELISA) and a passive haemagglutination test (PHT) for the detection of pseudomonas antibodies in burned patients.
Roe EA; Jones RJ
Burns Incl Therm Inj; 1985 Apr; 11(4):252-8. PubMed ID: 3924353
[TBL] [Abstract][Full Text] [Related]
10. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
11. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
Roe EA; Jones RJ
Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
Matthews-Greer JM; Gilleland HE
J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa: prevention better than cure?
Mellor JA; Miler JJ
Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
Jones RJ; Roe EA; Gupta JL
Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
[TBL] [Abstract][Full Text] [Related]
16. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
[No Abstract] [Full Text] [Related]
17. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
18. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
19. Serological failure of Pseudomonas vaccination in patients receiving multiple chemotherapy.
Bannister P; Mellor J
J Biol Stand; 1985 Oct; 13(4):321-6. PubMed ID: 3932361
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
Lieberman MM
Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
[No Abstract] [Full Text] [Related]
[Next] [New Search]